New drug aims to reverse liver damage from heavy drinking
Disease control
Recruiting now
This study tests a weekly injection called pemvidutide in 100 adults with alcohol-related liver disease. The goal is to see if it can reduce liver stiffness, a sign of liver damage, over 24 weeks. Participants must be overweight, have a history of heavy drinking, and have moderat…
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated May 17, 2026 13:23 UTC